Medicare Enrolled

Dr. Kelly Carson, M.D.

Gastroenterology · Atlanta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5669 PEACHTREE DUNWOODY RD NE, Atlanta, GA 30342
4042554333
In practice since 2006 (20 years)
NPI: 1801859327 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carson

Dr. Kelly Carson is a gastroenterology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Carson performed 834 Medicare services across 798 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carson received a total of $6,328 from 39 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in GA $6,328 industry payments

Medicare Practice Summary

Medicare Utilization ↗
834
Medicare services
Top 32% in GA for gastroenterology
798
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~42 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
222 $95 $325
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
156 $202 $1,188
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
119 $123 $408
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
116 $67 $275
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
54 $81 $870
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
50 $63 $931
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
45 $183 $702
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $136 $425
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $69 $225
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
14 $183 $702
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
11 $84 $611
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,328
Total received (2018-2024)
Avg $904/year across 7 years
Top 33% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,328 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,740
2023
$1,545
2022
$1,239
2021
$730
2020
$319
2019
$722
2018
$33

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$440
GENZYME CORPORATION
$229
Takeda Pharmaceuticals U.S.A., Inc.
$184
PFIZER INC.
$158
Lilly USA, LLC
$106
Regeneron Healthcare Solutions, Inc.
$96
Celgene Corporation
$67
Intercept Pharmaceuticals, Inc.
$66
Ipsen Biopharmaceuticals, Inc
$64
Organon Llc
$61
Madrigal Pharmaceuticals
$58
QOL Medical, LLC
$53
Celltrion USA Inc.
$44
AIMMUNE THERAPEUTICS, INC.
$39
Phathom Pharmaceuticals, Inc.
$32
Merck Sharp & Dohme LLC
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Top 3 companies account for 49.0% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$967
ABBVIE INC.
$791
AbbVie Inc.
$539
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$478
GENZYME CORPORATION
$459
PFIZER INC.
$394
Celgene Corporation
$393
Regeneron Healthcare Solutions, Inc.
$297
Janssen Biotech, Inc.
$228
AbbVie, Inc.
$183
Lilly USA, LLC
$140
Ironwood Pharmaceuticals, Inc
$133
Merck Sharp & Dohme LLC
$123
QOL Medical, LLC
$113
Ferring Pharmaceuticals Inc.
$110
INTERCEPT PHARMACEUTICALS, INC.
$101
Allergan Inc.
$72
Intercept Pharmaceuticals, Inc.
$66
Ipsen Biopharmaceuticals, Inc
$64
Daiichi Sankyo Inc.
$64
Braintree Laboratories, Inc.
$62
Organon Llc
$61
Organon LLC
$60
Madrigal Pharmaceuticals
$58
Celltrion USA Inc.
$44
Blueprint Medicines Corporation
$43
AIMMUNE THERAPEUTICS, INC.
$39
Medtronic, Inc.
$35
Phathom Pharmaceuticals, Inc.
$32
RedHill Biopharma Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Romark Laboratories, LC
$22
VIVUS LLC
$20
Nestle HealthCare Nutrition Inc.
$19
Prometheus Laboratories Inc.
$16
Micro-tech Endoscopy USA, Inc.
$13
Fresenius Kabi USA, LLC
$13
Allergan, Inc.
$13
IRONWOOD PHARMACEUTICALS, INC
$12
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
APRISO · Alinia · Bylvay · CIMZIA · CLENPIQ · CREON · CYLTEZO · Creon · DIFICID · DUPIXENT · ENTYVIO · Entyvio · GATTEX · HUMIRA · Humira · IDACIO · INJECTAFER · INTERSTIM · IQIRVO · LINZESS · LesionHunter · Linzess · MOTEGRITY · MOTOFEN · OCALIVA · OMVOH · QSYMIA · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TRULANCE · Talicia · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VRAYLAR · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Atlanta?
Compare gastroenterologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
231
Per 100K population
21.6
County median income
$91,490
Nearest hospital
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Carson is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Carson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Carson performed 222 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carson receive payments from pharmaceutical companies?
Yes. Dr. Carson received a total of $6,328 from 39 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carson's costs compare to other gastroenterologists in Atlanta?
Dr. Carson's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →